Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the diabetic ketoacidosis (dka) market size evolved in recent years?

There has been considerable growth in the market size for diabetic ketoacidosis (DKA) in the past few years. The market is projected to increase from $2.90 billion in 2024 to $3.16 billion in 2025, with a compound annual growth rate (CAGR) of 8.8%. The historical growth can be traced back to the surge in the number of diabetes cases, late detection of type 1 diabetes, non-compliance with insulin therapy, rising obesity figures, and scarcity of diabetes awareness initiatives.

What are the predictions for the diabetic ketoacidosis (dka) market size in the coming years?

Expect robust expansion of the Diabetic Ketoacidosis (DKA) market in the coming years, with an anticipation for it to reach $4.37 billion in value by 2029. This translates into a compound annual growth rate (CAGR) of 8.5%. Various factors, such as developments in insulin delivery methods, growing usage of continuous glucose monitoring, increased diabetes complication awareness, telemedicine growth for diabetes treatment, and elevated healthcare expenditure all contribute to this projected growth. Essential trends for the forecast period feature artificial intelligence implementation in diabetes treatment, the creation of closed-loop insulin delivery systems, customised medication, cutting-edge technologies, and innovative therapies.

Get your diabetic ketoacidosis (dka) market report here!

https://www.thebusinessresearchcompany.com/report/diabetic-ketoacidosis-dka-global-market-report

What key factors are fueling the growth of the diabetic ketoacidosis (dka) market?

Pushing the growth of the diabetic ketoacidosis (DKA) market is the escalating occurrence of obesity. Obesity is a health condition marked by an excessive accumulation of body fat, which potentially has negative health implications and heightens the risk of several diseases. The progressing rise of obesity is due to multiple factors such as unhealthy diets filled with processed foods, sugars, and fats, the lack of physical activity, elongated screen time, and social-economic aspects like the accessibility of inexpensive healthy food and health services. The likelihood of diabetic ketoacidosis (DKA) multiplies with obesity rates since it aids in insulin resistance and the emergence of type 2 diabetes, producing poor blood sugar management and ensuing DKA incidents. For instance, in March 2024, the World Health Organization (WHO), an intergovernmental establishment based in Switzerland, stated that approximately one-eighth of the global population is battling obesity. It included 2.5 billion adults (aged 18 years and above) who had excessive weight, with 890 million of them dealing with obesity. Among adults, 43% had excessive weight, and 16% were identified as obese. In addition, 37 million children under the age of 5 were overweight. Therefore, the escalating occurrence of obesity propels the growth of the diabetic ketoacidosis market.

How is the global diabetic ketoacidosis (dka) market divided into key segments?

The diabetic ketoacidosis (DKA) market covered in this report is segmented –

1) By Type: Pediatric Diabetic Ketoacidosis, Adult Diabetic Ketoacidosis

2) By Treatment Type: Fluid Replacement, Electrolyte Replacement, Insulin Therapy, Intermediate-Acting Insulin, Long-Acting Insulin

3) By Route of Administration: Oral, Parenteral, Other

4) By Distribution Channel: Online Channel, Offline Channel

5) By End Use: Hospitals, Ambulatory Care Center, Specialty Clinics

Subsegments:

1) By Pediatric Diabetic Ketoacidosis: Mild Pediatric DKA, Moderate Pediatric DKA, Severe Pediatric DKA

2) By Adult Diabetic Ketoacidosis: Mild Adult DKA, Moderate Adult DKA, Severe Adult DKA

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21168&type=smp

Who are the key firms paving the way for growth in the diabetic ketoacidosis (dka) market?

Major companies operating in the diabetic ketoacidosis (DKA) market are Merck And Co. Inc., Pfizer Inc., Sanofi S.A., Bristol Myers Squibb, Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., B. Braun Medical Inc., Fresenius Kabi, Merit Pharmaceutical, Oramed Pharmaceuticals Inc., ICU Medical Inc., Tonghua Dongbao Pharmaceutical Co. Ltd., Wockhardt Ltd., Biocon Limited

How are evolving market trends shaping diabetic ketoacidosis (dka) Strategies?

A large number of companies active in the diabetic ketoacidosis (DKA) market are concentrating on the creation of innovative technological solutions, including continuous glucose monitoring devices, to enhance early discovery, superior regulation of blood glucose and ketone levels, and eventually diminish the occurrence and harshness of DKA in individuals with diabetes. Continuous Glucose Monitoring (CGM) devices are instrumental tools that provide continual supervision of glucose levels in the body, presenting instant data which aids individuals with diabetes in controlling their blood sugar levels. For example, in June 2022, a USA-based healthcare technology company, Abbott Laboratories, rolled out novel systems that continuously monitor glucose and ketone levels. This revolutionary system provides real-time combined monitoring of glucose and ketone levels, giving a comprehensive insight into a patient’s metabolic condition. It facilitates the early identification of possible diabetic complications like diabetic ketoacidosis (DKA) before they escalate to severe levels. This system has been engineered for unceasing monitoring, giving users regular and convenient data updates without the necessity for manual testing.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21168

What regions are contributing significantly to the growth of the diabetic ketoacidosis (dka) market?

North America was the largest region in the diabetic ketoacidosis (DKA) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic ketoacidosis (DKA) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Neurotoxin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurotoxin-global-market-report

Rare Neurological Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Global Biosimilar Hormones Global Market Report 2025

https://thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: